WHO endorses GSK's malaria vaccine for children, the first against the mosquito-borne disease that kills more than 400,000 a year
File photo: A nurse of Ewin Polyclinic takes Malaria vaccine Mosquirix from a bottle to administer it to a baby, at Pempamsie Hotel, Cape Coast, Ghana, on April 30, 2019.
"Today, WHO is recommending the broad use of the world's first malaria vaccine," said Ghebreyesus on Wednesday. While Mosquirix is the first to be authorised, it is only about 30 percent effective, requires up to four doses, and protection fades after just months.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
WHO experts back using malaria vaccine on African children'Today's recommendation offers a glimmer of hope for the continent which shoulders the heaviest burden of the disease,' said the WHO's Africa director.
続きを読む »
Historic go-ahead for malaria vaccine to protect African childrenAfter years of trials, the vaccine has shown potential to save tens of thousands of children's lives.
続きを読む »
'Historic Moment': W.H.O. Approves Rollout Of World's First Malaria VaccineThe malaria vaccine known as Mosquirix was developed by GlaxoSmithKline in 1987.
続きを読む »
World’s First Malaria Vaccine Gets WHO BackingThe World Health Organization recommended the widespread deployment of the GlaxoSmithKline vaccine to young children in sub-Saharan Africa and other at-risk regions, hoping to revive the fight against the mosquito-borne illness.
続きを読む »
Jennifer Lawrence Feels ‘Grounded and Ready’ to Become a MomJennifer's rep recently confirmed that the actress is pregnant with her first child.
続きを読む »